AnnSofie Sternas - Karolinska Development Insider

KDEV -- Sweden Stock  

SEK 9.40  0.12  1.29%

Ms. AnnSofie Sternas was Vice President IPR at Karolinska Development AB since June 2012. She is European Patent Attorney and holds MS in Chemical Engineering. AnnSofie Sternas has almost 20 years of IP experience from large pharmaceutical companies and has held senior IPR positions within Astra and AstraZeneca. During many years AnnSofie was heavily involved in IP litigation of several blockbuster drugs. AnnSofie is specialized in IPstrategic matters with a heavy focus on the US legislation particularly IP in the interface between patent law and regulatory law. She is also part of a number of management teams within the Karolinska Development portfolio companies.
Age: 53  President Since 2012      
46 8 52 48 60 70

Management Efficiency

The company has return on total asset (ROA) of (4.09) % which means that it has lost $4.09 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of 119.32 % meaning that it generated $119.32 on every $100 dollars invested by stockholders.
The company has accumulated 391.46 M in total debt with debt to equity ratio (D/E) of 158.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Karolinska Development AB has Current Ratio of 16.14 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Entity Summary

Karolinska Development AB is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. Karolinska Development AB was founded in 2003 and is headquartered in Stockholm, Sweden. Karolinska Development operates under Pharmaceuticals And Biosciences classification in Sweden and traded on Stockholm Stock Exchange. It employs 7 people.Karolinska Development AB (KDEV) is traded on Stockholm Stock Exchange in Sweden. It is located in Tomtebodav?gen 23 A and employs 7 people.

Karolinska Development AB Leadership Team

Hans Wigzell, Independent Chairman of the Board
Elisabet Gimbringer, Controller
Carl Sundberg, Director
Magnus Persson, Director
Jim Heusden, CEO
Maria Ferm, Executive Assistant
HansOlov Olsson, Director
Theresa Tse, Director
Viktor Drvota, Chief Investment Officer
Eva Montgomerie, Head of Accounting
Michael Owens, Controller
Yan Cheng, President Asia
Ulf Richenberg, General Counsel
Niclas Adler, Director
Tse Ping, Director
Christian Tange, CFO
Daniel Bolanowski, Business Analyst
Terje Kalland, Chief Scientific Officer
Vladimir Artamonov, Independent Director
Felicia Rittemar, Analyst
AnnSofie Sternas, Vice President IPR
Anders Harfstrand, Director
Bo Hansen, Chairman of the Board
Fredrik Jarrsten, CFO
Khalid Islam, Director
Gunilla Ekstrom, Vice President - Operations
Henrijette Richter, Director

Stock Performance Indicators

Did you try this?

Run Global Markets Map Now

Global Markets Map

Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
All  Next Launch Global Markets Map

Build Optimal Portfolios

Align your risk with return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see also Stocks Correlation. Please also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.